Craig Thompson Awarded Columbia Business School’s Deming Cup for Operational Excellence
Craig B. Thompson, MD, President and CEO at MSK, was awarded Columbia Business School’s Deming Cup for Operational Excellence. Dr. Thompson and MSK were recognized with this prestigious award for leadership during the ongoing COVID-19 pandemic. Fellow 2020 honorees include healthcare leaders Michael Dowling, President and CEO of Northwell Health, and Kevin Sowers, MSN, RN, FAAN, President of the Johns Hopkins Health System and Executive Vice President of Johns Hopkins Medicine.
Ingo Mellinghoff Named Chair of MSK’s Department of Neurology
Neuro-oncologist Ingo K. Mellinghoff, MD, was appointed MSK’s new Chair of the Department of Neurology. Dr. Mellinghoff currently holds the Evnin Family Chair in Neuro-Oncology and runs a research lab in the Human Oncology and Pathogenesis Program. He is also Professor of Neurology and Professor of Neuroscience in the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine. Dr. Mellinghoff previously served as Chief of the MSK Brain Tumor Service and Vice Chair of Research in MSK’s Department of Neurology.
Tomya Watt Named Recipient of Inaugural 2020 iCIMS Innovator Award
Tomya Watt, Vice President of Talent Acquisition and Mobility and Chief Diversity Officer, was named one of the winners of the 2020 iCIMS Innovator Awards. iCIMS, the talent cloud company that empowers employers to attract, engage, hire, and advance the world’s best talent, recognized 20 talent leaders for their creativity, dedication, and transformation in its first-ever Innovator Awards.
Ms. Watt is also one of the speakers at iCIMS’s inaugural INSPIRE conference, which is being held virtually on November 18.
Four MSK Researchers Receive 2020 Outstanding Investigator Awards from the National Cancer Institute
Four distinguished researchers at MSK and Sloan Kettering Institute (SKI), Joan Massagué, PhD; Maria Jasin, PhD; David A. Scheinberg, MD, PhD; and Hans-Guido Wendel, MD, were named recipients of the National Cancer Institute’s (NCI) 2020 Outstanding Investigator Award (OIA). As part of this exceptional award, the NCI will provide each investigator with up to $600,000 per year for seven years to support their research.
The NCI’s OIA supports investigators and accomplished leaders in cancer research who have been nominated by their respective institutions and are providing significant contributions in the field of cancer and developing treatments and tools that may lead to breakthroughs in biomedical, behavioral, or clinical cancer research.
Lisa DeAngelis Receives Oligo Nation’s Lifetime Achievement Award
Lisa DeAngelis, MD, Physician-in-Chief and Chief Medical Officer of MSK, was awarded Oligo Nation’s Lifetime Achievement Award for her leadership in the field of neuro-oncology. MSK nurse Elizabeth Schille, RN, OCN, was also honored with Oligo Nation’s Compassionate Care Award. Ms. Schilles has worked in both the inpatient and outpatient clinic setting at MSK for 20 years.
Jedd Wolchok Receives Hearst Foundation Grant
The William Randolph Hearst Foundation awarded Jedd Wolchok, MD, PhD, a $1 million grant over a three-year period to establish a new Immuno-Oncology Research Fellowship at MSK and support postdoctoral students who are conducting exceptional research in the field of immune-oncology and immunotherapy. The fellowship program will be a part of the Human Oncology and Pathogenesis Program’s (HOPP) Immuno-Oncology service, led by Dr. Wolchok.
Krishna Juluru Named 2021 Presidential Innovation Fellow
Krishna Juluru, MD, a radiologist and Director of Radiology Informatics, has begun a year-long “tour of duty” in the United States government as a 2021 Presidential Innovation Fellow. Through October 2021, Dr. Juluru will be on leave from MSK while he works with the National Institute of Biomedical Imaging and Bioengineering within the National Institutes of Health, where he will focus on advancing new technologies in COVID-19 diagnostics and coordinating data analytics.
Wouter Karthaus Named 2020 STAT Wunderkind
Alessia Pedoto Named an AWEsome Woman by Society of Cardiovascular Anesthesiologists
Alessia Pedoto, MD, Attending Physician in the anesthesiology department at MSK, was honored by the Society of Cardiovascular Anesthesiologists (SCA) as an AWEsome Woman in the SCA’s AWEsome Women (Anesthesiology Women of Excellence) initiative to recognize prominent women in the field.
Yan Leyfman Named City & State New York Manhattan Hero
Yan Leyfman, Research Assistant in the Michel Sadelain Lab, was named to City & State New York’s Manhattan Heroes issue. He is one of ten recipients who were recognized for going above and beyond during the 2020 COVID-19 pandemic and helping to improve the lives of Manhattan residents. As part of the joint task force between the American College of Academic International Medicine and the World Academic Council of Emergency Medicine, Mr. Leyfman meets weekly with an international group of researchers to exchange ideas and updates about how the virus is being treated and spreading around the world. With that group, Mr. Leyfman created a cohesive model of COVID-19 that demonstrates how it interacts with other cells.
Engineering News-Record Names David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center Best Healthcare Design Finalist
The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center was named a Best Healthcare and Project of the Year finalist by Engineering News-Record. The David H. Koch Center for Cancer Care at Memorial Sloan Kettering was designed to help restore patients’ health and well-being and offers chemotherapy, immunotherapy, radiation therapy, blood and marrow transplants, clinical trials, rehabilitation services, and much more.
About Memorial Sloan Kettering (MSK):As the world’s oldest and largest private cancer center, Memorial Sloan Kettering has devoted more than 135 years to exceptional patient care, influential educational programs, and innovative research to discover more effective strategies to prevent, control, and ultimately, cure cancer. MSK is home to more than 20,000 physicians, scientists, nurses, and staff united by a relentless dedication to conquering cancer. Today, we are one of 51 National Cancer Institute-designated Comprehensive Cancer Centers, with state-of-the-art science and technology supporting groundbreaking clinical studies, personalized treatment, and compassionate care for our patients. We also train the next generation of clinical and scientific leaders in oncology through our continually evolving educational programs, here and around the world. Year after year, we are ranked among the top two cancer hospitals in the country, consistently recognized for our expertise in adult and pediatric oncology specialties. www.mskcc.org